Novartis | NVS - Marktkapitalisierung

Aktienkurs
144.38
Täglich Wechseln
0.13 0.09%
Monatlich
-3.99%
Jährlich
27.27%
Q2 Prognose
142.62




Marktkapitalisierung Veränderung Datum
AbbVie USD 403.83B 5.2B 2025-12
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Bausch Health Companies USD 2.58B 194.9M 2025-12
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Canopy Growth CAD 656.46M 124.89M 2025-12
Corcept Therapeutics USD 3.66B 5.1B 2025-12
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Glaxosmithkline GBP 99.93B 13.05B 2025-12
J&J USD 561.65B 17.5B 2026-04
Merck USD 261.26B 51.62B 2025-12
Novartis USD 234.78B 72.98B 2026-04
Novartis USD 263.08B 17.01B 2025-12
Pacira USD 1.06B 94M 2025-12
Perrigo USD 1.92B 1.04B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.97B 105M 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
Sanofi EUR 117.34B 2.45B 2025-12
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
Zoetis USD 55.45B 9.4B 2025-12